Product correctly added to cart.

discount label
Celecoxib-d4
View 3D

Biosynth logo

Celecoxib-d4

CAS: 544686-20-6

Ref. 3D-UWA68620

1mgTo inquire
5mgTo inquire
10mgTo inquire
25mgTo inquire
50mgTo inquire
Estimated delivery in United States, on Tuesday 27 Aug 2024

Product Information

Name:
Celecoxib-d4
Description:

Celecoxib-d4 is a potent inhibitor of cyclooxygenase-2 (COX-2) that is used in the treatment of various types of cancer. It induces apoptosis in human cancer cells by inhibiting the activity of kinases such as protein kinase B (AKT) and extracellular signal-regulated kinase (ERK). Celecoxib-d4 has been shown to be effective against various types of tumors, including lung, breast, and colon cancers. This medicinal analog has been extensively studied in Chinese hamster ovary cells and has been found to be a potent inhibitor of cyclin-dependent kinases. Celecoxib-d4 is one of the most promising anticancer drugs available today, with its potent anti-tumor effects and minimal side effects. It is an excellent choice for those seeking a reliable and effective treatment for cancer.

Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
385.4 g/mol
Formula:
C17H14F3N3O2S
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-UWA68620 Celecoxib-d4

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".